Aprogen Medicines Inc.

KSE 007460.KS

Aprogen Medicines Inc. Total Non-Current Liabilities for the year ending December 31, 2023: USD 39.24 M

Aprogen Medicines Inc. Total Non-Current Liabilities is USD 39.24 M for the year ending December 31, 2023, a 1.55% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Aprogen Medicines Inc. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 38.64 M, a 413.53% change year over year.
Aprogen Medicines Inc. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 7.53 M, a -86.15% change year over year.
Aprogen Medicines Inc. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 54.32 M, a 200.46% change year over year.
Aprogen Medicines Inc. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 18.08 M, a -79.74% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

KSE: 007460.KS

Aprogen Medicines Inc.

CEO	Ki-Cheol Lim
IPO Date	Sept. 29, 2005
Location	South Korea
Headquarters	Hallasigma valley (Sangdaewon-dong)
Employees	268
Sector	Materials
Industries Composite Materials Ceramics Construction Materials Glass Petrochemicals Plastics Pollution Treatment Steel

Description

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea.

Key trends

Past 5 years